Alexza Pharmaceuticals Inc (NASDAQ:ALXA)
CAPS Rating:
An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.
RSS Headlines
Fool UK
Recs
Cleaning up after 2 year hiatus from CAPS.